Xilio Therapeutics, Inc. (XLO) Open Interest History

Open interest tracks the total number of outstanding options contracts. Rising OI alongside price moves can indicate growing commitment to the trend; declining OI suggests positions are being closed.

Xilio Therapeutics, Inc. (XLO) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $49.4M, listed on NASDAQ, employing roughly 64 people, carrying a beta of -0.13 to the broader market. Xilio Therapeutics, Inc. Led by Rene Russo, public since 2021-10-22.

Open interest history tracks how outstanding options contracts change over time. No recent options activity for XLO as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how open interest is reported and how to read the data →